Unknown

Dataset Information

0

Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice.


ABSTRACT: Alterations in the gut microbiota play a crucial role in host physiology and metabolism; however, the molecular pathways underlying these changes in diet-induced obesity are unclear. Mechanistic target of rapamycin (mTOR) signaling pathway is associated with metabolic disorders such as obesity and type 2 diabetes (T2D). Therefore, we examined whether changes in the regulation of mTOR signaling induced by diet (a high-fat diet [HFD] or normal-chow diet) and/or therapeutics (resveratrol [a specific inhibitor of mTOR complex 1] or rapamycin [an inhibitor of both mTOR complex 1 and 2]) altered the composition of the gut microbiota in mice. Oral administration of resveratrol prevented glucose intolerance and fat accumulation in HFD-fed mice, whereas rapamycin significantly impaired glucose tolerance and exacerbated intestinal inflammation. The abundance of Lactococcus, Clostridium XI, Oscillibacter, and Hydrogenoanaerobacterium increased under the HFD condition; however, the abundance of these species declined after resveratrol treatment. Conversely, the abundance of unclassified Marinilabiliaceae and Turicibacter decreased in response to a HFD or rapamycin. Taken together, these results demonstrated that changes in the composition of intestinal microbiota induced by changes in mTOR activity correlate with obese and diabetic phenotypes.

SUBMITTER: Jung MJ 

PROVIDER: S-EPMC4965768 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice.

Jung Mi-Ja MJ   Lee Jina J   Shin Na-Ri NR   Kim Min-Soo MS   Hyun Dong-Wook DW   Yun Ji-Hyun JH   Kim Pil Soo PS   Whon Tae Woong TW   Bae Jin-Woo JW  

Scientific reports 20160729


Alterations in the gut microbiota play a crucial role in host physiology and metabolism; however, the molecular pathways underlying these changes in diet-induced obesity are unclear. Mechanistic target of rapamycin (mTOR) signaling pathway is associated with metabolic disorders such as obesity and type 2 diabetes (T2D). Therefore, we examined whether changes in the regulation of mTOR signaling induced by diet (a high-fat diet [HFD] or normal-chow diet) and/or therapeutics (resveratrol [a specifi  ...[more]

Similar Datasets

| S-EPMC7693779 | biostudies-literature
| S-EPMC6062601 | biostudies-literature
| S-EPMC7221029 | biostudies-literature
| S-EPMC7699645 | biostudies-literature
| S-EPMC7668533 | biostudies-literature
| S-EPMC7231103 | biostudies-literature
| S-EPMC7761388 | biostudies-literature
| S-EPMC6582896 | biostudies-literature
| S-EPMC4908688 | biostudies-literature
| S-EPMC4297748 | biostudies-literature